This study identifies GZMB and SPP1 as key immunosuppressive microenvironment-related prognostic biomarkers in IBC, establishes pDCs as central mediators of immunosuppressive niche remodeling, and offers novel therapeutic perspectives for immunotherapy in IBC. This evidence concerns the gene SPP1 and inflammatory breast carcinoma.